YOLARX Consultants is a privately-owned company that has successfully provided services in pharmacoepidemiology for almost 20 years. Since its inception in 2006, YOLARX has evolved into a boutique research organization with a North American headquarter in Montreal (Canada) and a European headquarter in Paris (France). A staff of 15 provides services in pharmacoepidemiology, data science, therapeutic risk management and pharmacovigilance, to a global client base of large, medium, and small pharmaceutical companies.

YOLARX has conducted projects in all therapeutic areas, including rare diseases, across all regions – critical and literature reviews (systematic, rapid/targeted, scoping, umbrella), data landscaping, feasibility assessment, data analysis, post-authorization safety studies. Our proprietary Yolarx SLRTM platform increases the efficiency of the literature reviews we conduct by leveraging AI technology, including natural language processing, for the selection of sources and data extraction. Our proprietary RWD Tracker© platform is a unique AI-powered online library of real-world data (RWD) sources. For each data landscaping project, YOLARX leads the industry in creating a knowledge base of data sources that is customized to our client’s business needs.

Our reputation is derived from well-established values: Quality, Innovation, Commitment, Respect, Collaboration, Responsibility & Reliability. The academic appointments and affiliations held by the members of our organization enhance the credibility of our work and are testimony of the high standards to which we adhere.

For additional information about our company and our services, please visit our website at: www.yolarx.com.